Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 1
2022 3
2023 1
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Hirschfield GM, Bowlus CL, Jones DEJ, Kremer AE, Mayo MJ, Tanaka A, Andreone P, Jia J, Jin Q, Macías-Rodríguez RU, Cobitz AR, Currie BM, Gorey C, Lazic I, Podmore D, Ribeiro A, Shannon JB, Swift B, McLaughlin MM, Levy C; GLISTEN Study Group. Hirschfield GM, et al. Lancet Gastroenterol Hepatol. 2026 Jan;11(1):22-33. doi: 10.1016/S2468-1253(25)00192-X. Epub 2025 Oct 28. Lancet Gastroenterol Hepatol. 2026. PMID: 41173016 Clinical Trial.
Negative prognostic impact of electrolyte disorders in patients hospitalized for Covid-19 in a large multicenter study.
Genovesi S, Regolisti G, Rebora P, Occhino G, Belli M, Molon G, Citerio G, Beltrame A, Maloberti A, Generali E, Giannattasio C, Epis OM, Rossetti C, Bellelli G, De Nalda AL, Capua I, Valsecchi MG. Genovesi S, et al. Among authors: de nalda al. J Nephrol. 2023 Apr;36(3):621-626. doi: 10.1007/s40620-022-01429-3. Epub 2022 Aug 24. J Nephrol. 2023. PMID: 36001295 Free PMC article.
Correction: Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
Lanza E, Masetti C, Messana G, Muglia R, Pugliese N, Ceriani R, de Nalda AL, Rimassa L, Torzilli G, Poretti D, D'Antuono F, Politi LS, Pedicini V, Aghemo A; Humanitas HCC Multidisciplinary Group. Lanza E, et al. Among authors: de nalda al. PLoS One. 2020 Oct 28;15(10):e0241715. doi: 10.1371/journal.pone.0241715. eCollection 2020. PLoS One. 2020. PMID: 33113549 Free PMC article.
The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern Italy.
Desai A, Voza G, Paiardi S, Teofilo FI, Caltagirone G, Pons MR, Aloise M, Kogan M, Tommasini T, Savevski V, Stefanini G, Angelini C, Ciccarelli M, Badalamenti S, De Nalda AL, Aghemo A, Cecconi M, Martinelli Boneschi F, Voza A; Humanitas COVID-19 task force. Desai A, et al. Among authors: de nalda al. Int J Cardiol. 2021 Feb 1;324:249-254. doi: 10.1016/j.ijcard.2020.09.062. Epub 2020 Sep 25. Int J Cardiol. 2021. PMID: 32980434 Free PMC article.
Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
Lanza E, Masetti C, Messana G, Muglia R, Pugliese N, Ceriani R, Lleo de Nalda A, Rimassa L, Torzilli G, Poretti D, D'Antuono F, Politi LS, Pedicini V, Aghemo A; Humanitas HCC Multidisciplinary Group. Lanza E, et al. Among authors: lleo de nalda a. PLoS One. 2020 Jun 17;15(6):e0232371. doi: 10.1371/journal.pone.0232371. eCollection 2020. PLoS One. 2020. PMID: 32555707 Free PMC article.